Lipoprotein Modulation of Subendothelial Heparan Sulfate Proteoglycans (Perlecan) and Atherogenicity

Publisher： Elsevier

ISSN： 1050-1738

Source： Trends in Cardiovascular Medicine, Vol.10, Iss.2, 2000-02, pp. : 60-65

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Modulation of Microvascular Signaling by Heparan Sulfate Matrix: Studies in Syndecan-4 Transgenic Mice

By Li J. Parovian C. Li J. Hampton T.G. Metais C. Tkachenko E. Sellke F.W. Simons M.

Microvascular Research, Vol. 64, Iss. 1, 2002-07 ,pp. : 38-46

Academic Press

Access to resources Recommend Favorite

Aggravation of acute pancreatitis by heparan sulfate in mice

By Liu Hongxiang Li Yuan Wang Ling Chen Hongying Guan Jianting Zhou Zongguang

Scandinavian Journal of Gastroenterology, Vol. 44, Iss. 5, 2009-05 ,pp. : 626-632

Informa Healthcare

Access to resources Recommend Favorite

“European Panel on Low Density Lipoprotein (LDL) Subclasses”: A Statement on the Pathophysiology, Atherogenicity and Clinical Significance of LDL Subclasses

Current Vascular Pharmacology, Vol. 9, Iss. 5, 2011-09 ,pp. : 533-571

Bentham Science Publishers

Access to resources Recommend Favorite

“European Panel On Low Density Lipoprotein (LDL) Subclasses”: A Statement on the Pathophysiology, Atherogenicity and Clinical Significance of LDL Subclasses: Executive Summary

Current Vascular Pharmacology, Vol. 9, Iss. 5, 2011-09 ,pp. : 531-532

Bentham Science Publishers

Access to resources Recommend Favorite

Further evidence on the role of heparan sulfate as protamine acceptor during the decondensation of human spermatozoa

By Romanato Marina

Human Reproduction, Vol. 20, Iss. 10, 2005-10 ,pp. : 2784-2789

Oxford University Press

Access to resources Recommend Favorite